… Dr Packer is a consultant to and Drs Lo and Fasanmade are employees of Centocor, Inc, …
17 St Clair EW, Wagner C, Fasanmade A, et al. The relationship of serum infliximab …

Objective To investigate the relationship between serum concentrations of infliximab, a
monoclonal anti–tumor necrosis factor α antibody, and clinical improvement from infliximab …

Flavonoids occurring in Vemonia amygdalina leaves have been studied. Three flavones
were identified with chemical and spectroscopic techniques. They were identified as luteolin, …

Purpose Infliximab, a monoclonal antibody, is approved for the treatment of inflammatory
diseases at doses that depend on the patient disease population. It was the aim of this study to …

BACKGROUND: Infliximab is a chimeric monoclonal antibody against TNFα. The pharmacokinetic
(PK) properties of infliximab have been studied in several adult patient populations, …

Objectives Infliximab, an IgG1 monoclonal antibody (mab), has large inter-individual serum
concentration variability. The objective was to determine the extent of the association of …

Background Vedolizumab, an anti‐α 4 β 7 integrin monoclonal antibody ( mA b), is indicated
for treating patients with moderately to severely active ulcerative colitis ( UC ) and Crohn's …

Background: Diabetes Mellitus is the commonest endocrine-metabolic disorder in Nigeria
similar to the experience in other parts of the world. The aim was to assess the clinical and …

Background Benefits and risks of concomitant immunomodulators and maintenance infliximab
in inflammatory bowel disease (IBD) patients have not been adequately evaluated. Aim …

Objective: Infliximab monotherapy provided a rapid and high degree of clinical benefit in
patients with moderate to severe psoriasis in a previously conducted trial. Herein we describe …